Ariel Sutton, EVP and GM of Imperative Care’s Stroke business, discusses the Imperative Trial, the company’s Zoom Insert Catheters and more in an interview with SmartTRAK at SNIS 2024.
Imperative Care’s Ariel Sutton, executive vice president and general manager of the company’s Stroke business, discusses results from the Imperative Trial, what it means for the acute ischemic stroke (AIS) market and the company’s newest innovations in an interview with SmartTRAK at the Society of NeuroInterventional Surgeons (SNIS) 21st Annual meeting in Colorado Springs, CO held July 22 to 26, 2024.
To find out more, listen to the following video (15:54 minutes). A link to download the complete transcript of the interview is also provided below.
Interview Transcript (scroll down to download the complete transcript)
SmartTRAK: Anne Staylor here with SmartTRAK. Today I am speaking with Ariel Sutton, EVP and GM of Imperative Care Stroke Business, live from the Society of NeuroInterventional Surgeons annual meeting in Colorado Springs. Ariel, thank you for talking with me today.
Ariel Sutton: Thank you for having me.
Let's start by having you talk about Imperative Care's presence at SNIS. What's important for us to know?
AS: We’re really excited to share the results of the Imperative Trial at SNIS this year. This is a 260-patient prospective trial across 26 centers in the US, evaluating the clinical benefits of the Zoom Stroke Solution, including aspiration with our Zoom 88 catheters. The results from the trial showed high reperfusion rates of 82.2% TICI 2B+, which is similar to previous studies that were submitted to the FDA for 510(k) clearance for reperfusion indication. There are a few metrics that we think are important to highlight from the trial. First is ...
Click the button below to download and read the full transcript of the interview "SNIS 2024: An Interview with Imperative Care's Ariel Sutton" , conducted by Anne Staylor, SmartTRAK's Executive Editor and VP & GM of Neuro Therapies. 
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
